Last Updated on Nov 13, 2026

Current Cancer Drug Targets- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers

Abbreviation: Curr. Cancer Drug Targets




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.95

SJR

 0.726

h-Index

 109

Rank

 7884

Important Details

Title Current Cancer Drug Targets
Standard Abbreviation Curr. Cancer Drug Targets
Type of Publication Journal
Discipline Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3); Oncology (Q3)
Impact Score 2.95
SCImago Journal Rank (SJR) 0.726
h-index 109
Overall Rank 7884
Publisher Name Bentham Science Publishers
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 15680096, 18735576
Coverage and History 2001-2026
Best Quartile Q2
Total Citations Received
(Last 3 Year)
734

About Current Cancer Drug Targets


Current Cancer Drug Targets is a journal published by Bentham Science Publishers. This journal covers the area[s] related to Drug Discovery, Pharmacology, Cancer Research, Oncology, etc. The coverage history of this journal is as follows: 2001-2026. The rank of this journal is 7884. This journal's impact score, h-index, and SJR are 2.95, 109, and 0.726, respectively. The ISSN of this journal is/are as follows: 15680096, 18735576.

The best quartile of Current Cancer Drug Targets is Q2. This journal has received a total of 734 citations during the last three years (Preceding 2025).


Current Cancer Drug Targets Impact Score 2025-2026


The latest impact score (IS) of the Current Cancer Drug Targets is 2.95. It is computed in the year 2026 as per its definition and based on Scopus data. 2.95

It is decreased by a factor of around 0.08, and the percentage change is -2.64% compared to the preceding year 2024, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Current Cancer Drug Targets Impact Score 2026


Impact Score 2025 of Current Cancer Drug Targets is 2.95. If a similar downward trend continues, IS may decrease in 2026 as well.


Impact Score Graph


Check below the Impact Score trends of Current Cancer Drug Targets. This is based on Scopus data.


Year Impact Score (IS)
2026/2027 Coming Soon
2025 2.95
2024 3.03
2023 2.34
2022 2.95
2021 2.75
2020 3.06
2019 2.60
2018 2.15
2017 2.20
2016 2.81
2015 4.16
2014 3.87

Current Cancer Drug Targets h-index


  Table Setting

The h-index of Current Cancer Drug Targets is 109. By definition of the h-index, this journal has at least 109 published articles with more than 109 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Current Cancer Drug Targets ISSN


The International Standard Serial Number (ISSN) of Current Cancer Drug Targets is/are as follows: 15680096, 18735576.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Current Cancer Drug Targets Ranking and SCImago Journal Rank (SJR)


The Current Cancer Drug Targets is ranked 7884 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.726.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Current Cancer Drug Targets Publisher


Table Setting

The publisher of Current Cancer Drug Targets is Bentham Science Publishers. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 2001-2026.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Current Cancer Drug Targets is Curr. Cancer Drug Targets. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Curr. Cancer Drug Targets') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Current Cancer Drug Targets


If your area of research or discipline is related to Drug Discovery, Pharmacology, Cancer Research, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Current Cancer Drug Targets?

The latest impact score of Current Cancer Drug Targets is 2.95. It is computed in the year 2026.


What is the h-index of Current Cancer Drug Targets?

The latest h-index of Current Cancer Drug Targets is 109. It is evaluated in the year 2026.


What is the SCImago Journal Rank (SJR) of Current Cancer Drug Targets?

The latest SCImago Journal Rank (SJR) of Current Cancer Drug Targets is 0.726. It is calculated in the year 2026.


What is the ranking of Current Cancer Drug Targets?

The latest ranking of Current Cancer Drug Targets is 7884. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.


Who is the publisher of Current Cancer Drug Targets?

Current Cancer Drug Targets is published by Bentham Science Publishers. The publication country of this journal is United Arab Emirates.


What is the abbreviation of Current Cancer Drug Targets?

This standard abbreviation of Current Cancer Drug Targets is Curr. Cancer Drug Targets.


Is "Current Cancer Drug Targets" a Journal, Conference or Book Series?

Current Cancer Drug Targets is a journal published by Bentham Science Publishers.


What is the scope of Current Cancer Drug Targets?

The scope of Current Cancer Drug Targets is as follows:

  • Drug Discovery
  • Pharmacology
  • Cancer Research
  • Oncology

For detailed scope of Current Cancer Drug Targets, check the official website of this journal.


What is the ISSN of Current Cancer Drug Targets?

The International Standard Serial Number (ISSN) of Current Cancer Drug Targets is/are as follows: 15680096, 18735576.


What is the best quartile for Current Cancer Drug Targets?

The best quartile for Current Cancer Drug Targets is Q2.


What is the coverage history of Current Cancer Drug Targets?

The coverage history of Current Cancer Drug Targets is as follows 2001-2026.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Business: Theory and Practice Journal Vilnius Gediminas Technical University 18543 35 1.68
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3624 102 3.81
Journal of International Financial Management and Accounting Journal Wiley-Blackwell Publishing Ltd 2078 55 6.94
Journal of Supply Chain Management Journal Wiley-Blackwell 517 125 12.40
International Journal of Mathematical Education in Science and Technology Journal Taylor and Francis Ltd. 7829 48 1.43
Materials Research Journal Universidade Federal de Sao Carlos 17478 79 1.40
International Journal of Applied Linguistics Journal Wiley-Blackwell Publishing Ltd 3794 60 4.67
Abacus Journal Wiley-Blackwell Publishing Ltd 7390 60 3.20
Sex Education Journal Routledge 6742 55 3.30
Oral Radiology Journal Springer Japan 10403 32 2.54

Check complete list




Current Cancer Drug Targets Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2026/2027 Updated Soon
2025 2.95
2024 3.03
2023 2.34
2022 2.95
2021 2.75
2020 3.06
2019 2.60
2018 2.15
2017 2.20
2016 2.81
2015 4.16
2014 3.87



Top Journals/Conferences in Drug Discovery

RSC Drug Discovery Series
Royal Society of Chemistry | United Kingdom

Open Access Journal of Medicinal and Aromatic Plants
Medicinal and Aromatic Plants Association of India | India

Drug Discovery World
RJ Communications and Media Ltd. | United Kingdom

Journal of Pharmaceutical Negative Results
Wolters Kluwer Medknow Publications | India

See All

Top Journals/Conferences in Pharmacology

Human gene therapy methods
Mary Ann Liebert Inc. | United States

Frontiers in Clinical Drug Research - Alzheimer Disorders
Bentham Science Publishers B.V. | Netherlands

P and T
MediMedia USA Inc. | United States

Journal of Population Therapeutics and Clinical Pharmacology
Dougmar Publishing Group Inc. | Canada

Clinical Medicine Insights: Therapeutics
Libertas Academica Ltd. | New Zealand

Pharmacien Hospitalier et Clinicien
Elsevier Masson s.r.l. | France

PharmacoVigilance Review
Euromed Communications | United Kingdom

Clinical Pharmacist
Pharmaceutical Press | United Kingdom

Australian Journal of Pharmacy
Australian Pharmaceutical Publishing Company Ltd | Australia

Archivos Venezolanos de Farmacologia y Terapeutica
Sociedad Latinoamericana de Hipertension | Venezuela

Journal of Pharmaceutical Negative Results
Wolters Kluwer Medknow Publications | India

See All

Top Journals/Conferences in Cancer Research

Cancer Microenvironment
Springer Netherlands | Netherlands

See All

Top Journals/Conferences in Oncology

Cancer Microenvironment
Springer Netherlands | Netherlands

Current Colorectal Cancer Reports
Springer Science + Business Media | United States

Australian Journal of Cancer Nursing
Cambridge Media | Australia

Clinical Sarcoma Research
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

Onkopediatria
Paediatrician Publishers, LLC | Russian Federation

See All